- Home
- SNRE vs FOLD Comparison
SNRE vs FOLD Comparison
Compare SNRE & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNRE
- FOLD
- Stock Information
- Founded
- SNRE 2000
- FOLD 2002
- Country
- SNRE Switzerland
- FOLD United States
- Employees
- SNRE N/A
- FOLD N/A
- Industry
- SNRE Cable & Other Pay Television Services
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- SNRE Telecommunications
- FOLD Health Care
- Exchange
- SNRE Nasdaq
- FOLD Nasdaq
- Market Cap
- SNRE 3.4B
- FOLD 2.9B
- IPO Year
- SNRE N/A
- FOLD 2007
- Fundamental
- Price
- SNRE $49.08
- FOLD $7.95
- Analyst Decision
- SNRE
- FOLD Strong Buy
- Analyst Count
- SNRE 0
- FOLD 9
- Target Price
- SNRE N/A
- FOLD $17.00
- AVG Volume (30 Days)
- SNRE 311.7K
- FOLD 2.6M
- Earning Date
- SNRE 05-18-2025
- FOLD 05-08-2025
- Dividend Yield
- SNRE 7.59%
- FOLD N/A
- EPS Growth
- SNRE N/A
- FOLD N/A
- EPS
- SNRE N/A
- FOLD N/A
- Revenue
- SNRE $3,330,464,145.00
- FOLD $528,294,999.00
- Revenue This Year
- SNRE N/A
- FOLD $21.91
- Revenue Next Year
- SNRE N/A
- FOLD $22.22
- P/E Ratio
- SNRE N/A
- FOLD N/A
- Revenue Growth
- SNRE N/A
- FOLD 32.29
- 52 Week Low
- SNRE $42.35
- FOLD $7.90
- 52 Week High
- SNRE $50.67
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- SNRE N/A
- FOLD 27.83
- Support Level
- SNRE N/A
- FOLD $8.40
- Resistance Level
- SNRE N/A
- FOLD $8.62
- Average True Range (ATR)
- SNRE 0.00
- FOLD 0.25
- MACD
- SNRE 0.00
- FOLD -0.08
- Stochastic Oscillator
- SNRE 0.00
- FOLD 3.68
About SNRE Sunrise Communications AG American Depositary Shares representing Class A shares
Sunrise Communications AG is a telecommunications company. The company provides high-quality mobile, landline, broadband, and TV services to residential customers. The company also offers business customers 360-degree communications solutions and integrated ICT solutions for connectivity, security, and IoT from a single source to take companies forward in their quest for digitalization. It has three reportable segments being Residential customers; Business customers and Wholesale and Infrastructure and Support functions.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.